France· FR:64713443
TIANEPTINE BIOGARAN 12,5 mg, comprimé enrobé
A tianeptine product containing tianeptine sodique, registered in France by BIOGARAN, on the national reimbursement list. The same ATC class is registered in 5 of our 19 countries.
Checked against Base de données publique des médicaments — BDPM (France) on
Informational only — not a medical device.
Where it is registered
Tianeptine is registered in 5 of 19 countries.
Countries holding a registration under ATC N06AX14 (tianeptine), each read from that country’s own register.
- This record: France, from Base de données publique des médicaments — BDPM (France)
- 4 of them publish a price we can compare per daily dose
Tianeptine · ATC N06AX14
5 / 19 countries
- Czechiaprice
- Franceprice
- Germany
- Norwayprice
- Polandprice
Price per daily dose
What a daily dose of tianeptine costs, country by country.
Normalised to the WHO defined daily dose (37.5 mg), so markets compare like for like.
- France: $0.36 per daily dose (median across products in the class)
- Public list prices, converted to USD at the rate date shown
Tianeptine · price per daily dose (37.5 mg)
USD · FX 28 Sept 2026
- FR France$0.36
The record
At a glance
Base de données publique des médicaments — BDPM (France)- Active substance
- TIANEPTINE SODIQUE
- Manufacturer
- BIOGARAN
- Country
- France (FR)
- ATC code
- N06AX14
- ATC class
- Tianeptine
- Defined daily dose
- 37.5 mg, O
- Reimbursed
- Yes
- Source register
- Base de données publique des médicaments — BDPM (France)
- Last checked
- September 12, 2026
Packs & prices · 1
1 priced- cip133400926752392plaquette(s) PVC-Aluminium de 28 comprimé(s)EUR 2.96
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Tianeptine in 5 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaCOAXILLes Laboratoires Servier, Suresnes cedex
- PolandAtinepteZakłady Farmaceutyczne POLPHARMA S.A.
- GermanyTianesanHormosan Pharma Gmbh
- SpainZINOSAL 12,5 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFGExeltis Healthcare S.L.
- NorwayTianeuraxNeuraxpharm
Authorised across Europe · EMA
The same active substance is authorised in 17 EEA countries. Names it is sold under:
- Austria · Stablon
- Bulgaria · Коаксил
- Czechia · Coaxil
- Germany · Tianesan, Tianeurax
- Estonia · Coaxil, Salymbra
- Spain · Zinosal
- Greece · Tianeptine Liconsa
- Croatia · Coaxil, Neptika
- Hungary · Aneptinex, Coaxil
- Lithuania · Coaxil
- Luxembourg · Stablon
- Latvia · Coaxil
- Poland · Atinepte, Coaxil
- Portugal · Neluptin, Stablon
- Romania · Coaxil, Lyxit
- Slovenia · Coaxil
- Slovakia · Aneptinex, Coaxil
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/9662b74b-3b02-4614-b64e-51c13fcb687b GET /v1/drugs/9662b74b-3b02-4614-b64e-51c13fcb687b?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"cis": "64713443",
"date_amm": "1992-07-07",
"type_amm": "Procédure nationale",
"numero_ue": null,
"substance": "TIANEPTINE SODIQUE",
"atc_source": "fr_atc_restore_2026-09-06",
"statut_amm": "Autorisation active",
"statut_bdm": null,
"forme_pharmaceutique": "comprimé enrobé",
"voies_administration": "orale",
"etat_commercialisation": "Commercialisée",
"surveillance_renforcee": "Non"
}See everything about tianeptine.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.